Clik here to view.
Clik here to view.
Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials...
TOKYO & KOBE, Japan Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have signed an agreement for the...
View ArticleClik here to view.
Fujirebio与Sysmex签署免疫测定领域试剂原材料供应协议
日本东京和神户 (美国商业资讯)– Fujirebio Holdings, Inc.（总裁兼首席执行官：Goki Ishikawa）和Sysmex Corporation（总裁：Kaoru Asano）今天宣布，双方已经签署了一项相互供应各自拥有的试剂原材料的协议（以下简称“协议”）。本协议以两家公司于2023年10月签署的免疫测定领域业务合作基本协议*1为基础。...
View ArticleClik here to view.
PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by...
NEW YORK & TOKYO Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) today announced that on December 15, 2023 the U.S. Food and Drug...
View ArticleClik here to view.
Biocytogen Enters into Multi-Target Antibody Agreement With Neurocrine...
BEIJING & SAN DIEGO Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an antibody evaluation and option agreement with...
View ArticleClik here to view.
百奥赛图与Neurocrine Biosciences达成多靶点抗体协议
中国北京和美国圣地亚哥 (美国商业资讯)– 百奥赛图（北京）医药科技股份有限公司（“百奥赛图”，股票代码02315.HK）今日宣布与Neurocrine Biosciences, Inc.达成一项抗体评估与选择协议。该协议将许可Neurocrine...
View ArticleClik here to view.
Clik here to view.
海博艾斯旗下Normatec亮相中国，助力精英运动员和日常消费者恢复进程
加利福尼亚州尔湾 (美国商业资讯)– 全球高性能健康品牌海博艾斯（Hyperice）今日于中国推出全新产品Normatec。搭载空气压缩脉冲科技的Normatec有助于促进日常健康，可帮助更快恢复、改善训练水准，并最大限度地提升运动表现。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Hyperice Advances Performance for Elite Athletes and Everyday Consumers with...
IRVINE, Calif. Hyperice, a global high-performance wellness brand, today announced the introduction of Normatec, which uses dynamic air compression to advance everyday wellness and helps aid in...
View ArticleClik here to view.
JCR Announces Research Collaboration, Option and License Agreement with...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida: “JCR”) announces that it has signed a Research Collaboration, Option and License Agreement with Alexion,...
View ArticleClik here to view.
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that Takeda Pharmaceutical Co., Ltd. (“Takeda”) decided to discontinue their...
View ArticleClik here to view.
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to...
SAN DIEGO & SINGAPORE ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, announced a partnership with the Experimental Drug Development...
View ArticleClik here to view.
Syncell Expands Into the United States With a New Office in Watertown, MA
TAIPEI, Taiwan & WATERTOWN, Massachusetts Syncell, a life science technology company known for pioneering next-generation spatial proteomics, is pleased to announce the inauguration of its US...
View ArticleClik here to view.
Biocytogen and CtM Bio Achieve Milestone Progress in Co-Developing a...
BEIJING & SHANGHAI Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and CtM Biotech (Shanghai) Co., Ltd (“CtM Bio”) today jointly announce that the development of a...
View ArticleClik here to view.
CCM Biosciences宣布成立5Prime Sciences业务部
新泽西州芒特劳雷尔 (美国商业资讯)– 多元化生物技术公司CCM Biosciences (CCM Bio)宣布成立业务部门CCM 5Prime Sciences (5Prime)，专注于开发和应用DNA生物技术领域的专有技术。5Prime的技术平台包括多个受专利保护且已实现全球商业化的组合物和方法，用于分子克隆、下一代DNA测序和分子诊断。...
View ArticleClik here to view.
CCMバイオサイエンシズ、「5プライム・サイエンシズ」事業部の立ち上げを発表
マウント・ローレル、ニュー・ジャージー州 （ビジネスワイヤ） — バイオテクノロジー分野の多角経営企業であるCCMバイオサイエンシズ（CCMバイオ）は、DNAバイオテクノロジーの領域における独自テクノロジーの開発と応用に焦点を当てた事業部、CCM...
View ArticleClik here to view.
InnoCare to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428) announced today that Dr. Jasmine Cui, Co-founder, Chairwoman and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference, at 08:30...
View ArticleClik here to view.
Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for...
JIANGSU, China Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic...
View ArticleClik here to view.
Dr. Reddy’s Announces the Acquisition of MenoLabs®, a Leading Women’s Health...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”),...
View ArticleClik here to view.
Avistone Biotechnology Announces Closing of Series B Financing
BEIJING Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced...
View Article